Biblio

Journal Article
Drick N, Dahlmann J, Sahabian A, Haase A, Göhring G, Lachmann N, Ringshausen FC, Welte T, Martin U, Olmer R. Generation of two human induced pluripotent stem cell lines (MHHi017-A, MHHi017-B) from a patient with primary ciliary dyskinesia carrying a homozygous mutation (c.7915C > T [p.Arg2639*]) in the DNAH5 gene. Stem Cell Res. 2020;46:101848.
Bono F, Mutti V, Piovani G, Minelli A, Mingardi J, Guglielmi A, Fiorentini C, Barbon A, Missale C, Gennarelli M. Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression. Stem Cell Res. 2020;49:102104.
Peron C, Mauceri R, Iannielli A, Cavaliere A, Legati A, Rizzo A, Sciacca FL, Broccoli V, Tiranti V. Generation of two human iPSC lines, FINCBi002-A and FINCBi003-A, carrying heteroplasmic macrodeletion of mitochondrial DNA causing Pearson's syndrome. Stem Cell Res. 2021;50:102151.
Piechota M, Latoszek E, Liszewska E, Hansíková H, Klempíř J, Mühlbäck A, Landwehrmeyer GBernhard, Kuznicki J, Czeredys M. Generation of two human iPSC lines from dermal fibroblasts of adult- and juvenile-onset Huntington's disease patients and two healthy donors. Stem Cell Res. 2023;71:103194.
Sarkar H, Méjécase C, Harding P, Eintracht J, Toualbi L, Cunha DLima, Moosajee M. Generation of two human iPSC lines from patients with autosomal dominant retinitis pigmentosa (UCLi014-A) and autosomal recessive Leber congenital amaurosis (UCLi015-A), associated with RDH12 variants. Stem Cell Res. 2021;54:102449.
Aqel YWAbu, Ali G, Elsayed AK, Al-Khawaga S, Hussain K, Abdelalim EM. Generation of two human iPSC lines from patients with maturity-onset diabetes of the young type 2 (MODY2) and permanent neonatal diabetes due to mutations in the GCK gene. Stem Cell Res. 2020;48:101991.
Boeing A, Mavrommatis L, Daya NM, Zhuge H, Volke L, Kocabas A, Kneifel M, Athamneh M, Krause K, Südkamp N, et al. Generation of two human iPSC lines (HIMRi002-A and HIMRi003-A) derived from Caveolinopathy patients with rippling muscle disease. Stem Cell Res. 2023;72:103220.
Iuso A, Zhang F, Rusha E, Campbell B, Dorn T, Zanuttigh E, Haas D, Anikster Y, Lederer G, Pertek A, et al. Generation of two human iPSC lines, HMGUi003-A and MRIi028-A, carrying pathogenic biallelic variants in the PPCS gene. Stem Cell Res. 2022;61:102773.
Zanuttigh E, Rusha E, Peron C, Brunetti D, Zorzi G, Pertek A, Nteli P, Winkelmann J, Tiranti V, Iuso A. Generation of two human iPSC lines, HMGUi004-A and FINCBi004-A, from fibroblasts of MPAN patients carrying pathogenic recessive mutations in the gene C19orf12. Stem Cell Res. 2023;72:103197.
Tongkobpetch S, Rungsiwiwut R, Pruksananonda K, Suphapeetiporn K, Shotelersuk V. Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus. Stem Cell Res. 2019;39:101493.
Schuster J, Hoeber J, Sobol M, Fatima A, Annerén G, Dahl N. Generation of two human iPSC lines (UUIGPi013-A and UUIPGi014-A) from cases with Down syndrome and full trisomy for chromosome 21 (T21). Stem Cell Res. 2020;49:102081.
Zushin P-JH, Zhou Y, Li A, Ashley EA, Wheeler MT, Wu JC. Generation of two human iPSC lines with Exon 3 mutations in BCL2-Associated Athanogene 3 (BAG3) from dilated cardiomyopathy patients. Stem Cell Res. 2023;67:103019.
Merkert S, Jaboreck M-C, Engels L, Malik MNH, Göhring G, Pessler F, Martin U, Olmer R. Generation of two human ISG15 knockout iPSC clones using CRISPR/Cas9 editing. Stem Cell Res. 2020;50:102135.
Tandon R, Brändl B, Baryshnikova N, Landshammer A, Steenpaß L, Keminer O, Pless O, Müller F-J. Generation of two human isogenic iPSC lines from fetal dermal fibroblasts. Stem Cell Res. 2018;33:120-124.
Simons E, Nijak A, Loeys B, Alaerts M. Generation of two induced pluripotent stem cell (iPSC) lines (BBANTWi006-A, BBANTWi007-A) from Brugada syndrome patients carrying an SCN5A mutation. Stem Cell Res. 2022;60:102719.
Ahmad I, Goel D, Ghosh A, Kapoor H, Kumar D, Ramesh K, Ashley B, Deepika K, Shastry A, Faruq M. Generation of two induced pluripotent stem cell (iPSC) lines from patients with Duchenne muscular dystrophy (IGIBi006-A and IGIBi008-A) carrying exonic deletions in the dystrophin gene. Stem Cell Res. 2022;64:102927.
Chemla A, Arena G, Saraiva C, Berenguer-Escuder C, Grossmann D, Grünewald A, Klein C, Seibler P, Schwamborn JC, Krüger R. Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1. Stem Cell Res. 2023;69:103085.
Chemla A, Arena G, Önal G, Walter J, Berenguer-Escuder C, Grossmann D, Grünewald A, Schwamborn JC, Krüger R. Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.815G > A (p.R272Q) or c.1348C > T (p.R450C) in the RHOT1 gene encoding Miro1. Stem Cell Res. 2023;71:103145.
Vera CD, Manhas A, Shenoy SP, Wheeler MT, Sallam K, Wu JC. Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C. Stem Cell Res. 2022;63:102834.
McLenachan S, Zhang D, Zhang X, Chen S-C, Lamey T, Thompson JA, McLaren T, De Roach JN, Fletcher S, Chen FK. Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrier. Stem Cell Res. 2018;34:101357.
Jennings L, Zhang D, Chen S-C, Moon SYoon, Lamey T, Thompson JA, McLaren T, De Roach JN, Chen FK, McLenachan S. Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G>T and c.6079C>T mutations in ABCA4. Stem Cell Res. 2020;48:101947.
Zhang D, McLenachan S, Chen S-C, Zaw K, Alziyadat Y, Zhang X, Lamey TM, Thompson JA, McLaren TL, Mellough C, et al. Generation of two induced pluripotent stem cell lines from a patient with recessive inherited retinal disease caused by compound heterozygous mutations in SNRNP200. Stem Cell Res. 2021;51:102154.
Huang D, Zhang D, Chen S-C, Aung-Htut MThandar, Lamey TM, Thompson JA, McLaren TL, De Roach JN, Fletcher S, Wilton SD, et al. Generation of two induced pluripotent stem cell lines from a patient with Stargardt disease caused by compound heterozygous mutations in the ABCA4 gene. Stem Cell Res. 2021;54:102448.
Moon SYoon, Zhang D, Chen S-C, Lamey TM, Thompson JA, McLaren TL, De Roach JN, Chen FK, McLenachan S. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1. Stem Cell Res. 2021;54:102403.
Liu R, Qian K, Xiao Y, Jiang W. Generation of two induced pluripotent stem cell lines from blood cells of a prostate cancer patient carrying germline mutation in CHEK2. Stem Cell Res. 2021;53:102299.

Pages